Here's a sweet deal: The Cummings Foundation in Boston will make annual grant disbursements to top grantees for undefined extended periods of up to a decade—without making them apply for renewals.
After some serious listening, two of the biggest names in Boston philanthropy came together to support live arts performances and public art in a big way.
Many people who've watched family members struggle with problems like heroin addiction guard their privacy. Which is why a recent $25 million gift for addiction medicine is unusual—and important.
The success of the Pledge 1 Percent campaign shows how philanthropy norms are spreading rapidly in tech startups and early-stage companies, including at the local level. Here's how it's happened.
Yawkey has a legacy in Boston as a big supporter of youth sports and education for underprivileged kids. But lately, this foundation has been known for something quite a bit different.
An unexpected donation estimated at $28 million is set to push The Boston Foundation over the top and endow it with even greater giving capacity. Get ready local education groups, it's coming your way.
The Boston Foundation is not the first funder in Boston we might think of as leading the pushback to a Trump agenda. But last month it came forward with emergency grants for vulnerable groups.
In discussions about Boston philanthropy, two names come up over and over again: The Boston Foundation and the Barr Foundation. We take a comparative look at these top players.
The Boston Foundation recently announced the 2016 winners of a collaboration competition. This year’s challenge focused on uplifting youth voice and strengthening racial and community connections in the city.
Attorney General Healey announced a statewide grant fund for local programs geared toward opioid abuse education and prevention. A corporation is footing the bill.
When GE relocated to Boston with controversial tax breaks, it promised millions in new giving. One problem that immediately caught GE's attention was the devastation wrought by opioids.
It's a perennial tension at foundations: Stay laser-focused on key priorities or be more opportunistic. Here's how one funder is squaring the circle.